All News #Library
Intas’ Denosumab Receives Approval In Europe
17 Nov 2025 //
EMA
Intas Pharms` Generic Sitagliptin Receives Approval in the U.S.
02 Mar 2022 //
FDA
Intas`s Accofil (Filgrastim) Approved in Europe for Neutropenia
22 Feb 2015 //
BIOSPECTRUM

Market Place
Sourcing Support